Dr. Al-Ghazawi received his PhD from the School of Pharmacy, University of London, UK, 

and his B.Pharm., from Jordan University of Science and Technology, Jordan). 

Dr Al-Ghazawi is currently The Chairman of Triumpharma clinical evaluation center with 

strong emphasis on designing novel and new drug delivery systems and conducting 

bioequivalence and clinical trials, Which has been accredited by the JFDA, USFDA, EMA, 

GCC, and the Turkish authorities, Also Dr. Al-Ghazawi is The Managing Director of Savvy 

Pharma highly focused generic pharmaceutical company incorporated in 2011 by experienced 

team of scientific professorial that has successfully obtained GMP certificate in 2013 and was 

launched in Jordan market last quarter of 2016. In addition, Dr. Al-Ghazawi is the Chairman of 

Al-Mubadra for Medical Laboratories in Amman-Jordan. In addition, Dr. Al-Ghazawi is the 

Company Director of Savvy Consultancy limited for pharmaceutical consultation and business 

development services which was established in the UAE in 2017. 

Dr. Ahmad Al-Ghazawi has over 35 years of experience in the pharmaceutical sector with 

Merck, SmithKline & Norton Healthcare as a senior pharmaceutical scientist and as a technical 

& development manager and have been involved in designing and developing a novel dry 

powder inhaler and breath operated inhaler that won Prince Charles's Award for Innovation in 

UK,1994. Dr Al-Ghazawi was also a visiting a lecturer at School of Pharmacy pharmaceutical 

at University of Kent, Canterbury, UK. 

Dr Ahmad Al-Ghazawi is an inventor/co-inventor of over 6 patents in different pharmaceutical 

fields and drug delivery systems. One of the products he worked on achieved sales reached to $ 

2.2 billion/year in the USA. Dr. Al-Ghazawi was involved and is an inventor/co-inventor of 

several patents/patent applications in the many fields ​